The problem with prostate cancer is that there really are not any obvious symptoms. Men can present getting up at night to urinate, going frequently during the daytime; those really are all ...
This is usually to confirm and grade prostate cancer in a patient with an elevated serum PSA level or abnormal DRE of the prostate but serial biopsy is also used in patients with known low-risk ...
Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...
Medscape Medical News, June 06, 2019 ASCO 2019 More Is Not Better in Metastatic CR Prostate Cancer The combination of enzalutamide plus abiraterone is not more effective than enzalutamide alone ...
Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.
Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...
Here the authors report the results of a phase 1 trial of PSCA-directed autologous CAR-T cells with pharmacological activation by rimiducid in patients with metastatic pancreatic or prostate cancer.
The incidence of low- to intermediate-risk prostate cancer is rising owing to informal and formal prostate-specific antigen screening practices. The treatment burden from radical therapies is high ...
Bayer has won a key FDA approval to extend the use of its prostate cancer therapy Nubeqa, as it tries to claim market share from rival drugs and fulfil its aim of building the drug into a €3 ...
Background: In this population-based study, we investigated the degree of concordance between Gleason scores obtained from prostate biopsies and those obtained from prostatectomy specimens, as ...
CEO of Bayer UK & Ireland, Antonio Payano, said: “We are delighted that men with prostate cancer in England will have early access to another innovative treatment option.
No writing assistance was utilized in the production of this manuscript. Prostate cancer (PCa) is associated with a high economic burden in the USA. Several novel treatments for PCa have been ...